Boosting Stem Cell Potential Through Chemical Conditioning

Carlo Tremolada, Carlo Ventura · United States Patent Application Publication · 2015

A Special Compound May "Unlock" Healing Abilities in Adult Cells

This patent application from Lipogems International describes a laboratory process that could enhance the regenerative power of cells found in your own fat tissue. The researchers explored whether a specific chemical mixture could help adult cells behave more like younger, more versatile stem cells—without using genetic modification or viruses.

Your Fat Tissue Contains Valuable Healing Cells

Fat tissue (adipose tissue) is rich in pericytes and mesenchymal stem cells (MSCs)—cells that support blood vessel health and can develop into various tissue types. However, these adult cells have some natural limitations compared to embryonic stem cells. The Lipogems team investigated whether they could safely expand these cells' capabilities using a naturally-derived compound.

The Key Ingredient: A Modified Hyaluronic Acid Compound

The process centers on a molecule called HBR—hyaluronic acid combined with butyric acid and retinoic acid. Here's what each component brings:

  • Hyaluronic acid: A natural substance your body produces; it helps cells communicate and can enter cell nuclei

  • Butyric acid: Helps "open up" the cell's genetic material, making it more accessible

  • Retinoic acid: A vitamin A derivative known to influence how cells develop and specialize

When combined, these three elements work together to influence how genes are expressed in cells.

Previous Research Shows Promising Heart-Healing Results

Earlier studies using HBR demonstrated several benefits:

  • Enhanced heart muscle and blood vessel development in human MSCs from bone marrow, dental pulp, and placenta

  • Improved cardiovascular repair in both small (rat) and large (pig) animal models of heart attack

  • Increased production of beneficial growth factors like VEGF and HGF, which help form new blood vessels and protect tissue from damage

  • Heart repair even without transplanting stem cells—just by injecting the HBR compound directly

The Process Avoids Genetic Modification Concerns

Traditional methods for making adult cells more versatile often require inserting genes using viruses. This approach is expensive, complex, and raises safety concerns. The Lipogems patent describes a chemical-only process that:

  • Works with non-expanded tissue (meaning cells processed directly, not grown in a lab for weeks)

  • Uses your own tissue (autologous), reducing rejection risks

  • Avoids the need for viral gene delivery

  • May reprogram cells through natural biochemical pathways

What This Means for Regenerative Treatment Options

This patent represents foundational research into improving the healing potential of fat-derived cells. While the Lipogems system already preserves the natural regenerative properties of micro-fragmented adipose tissue (MFAT), this research explores ways to potentially enhance those properties further.

For patients considering regenerative treatments, this work suggests that fat tissue—easily accessible through minimally invasive procedures—may hold even greater therapeutic promise than previously understood. The ability to condition cells chemically, rather than genetically, could offer a safer path toward more powerful regenerative therapies.

It's important to note that this is a patent application describing laboratory processes, not a clinical trial in humans. The techniques described would need extensive testing before becoming part of standard treatment protocols. However, it demonstrates the ongoing scientific innovation behind Lipogems technology and the company's commitment to advancing regenerative medicine options.

---

Source: Tremolada et al., United States Patent Application Publication, 2015.

Original Publication

Chemical Preconditioning Process for Cell Material to Obtain Chemical Epigenetic Reprogramming and Pluripotency Expression

Carlo Tremolada, Carlo Ventura · United States Patent Application Publication · 2015

This invention relates to a chemical preconditioning process for cell material to obtain chemical epigenetic reprogramming and pluripotency expression of stem and multipotent elements of non-embryonic origin, such as pericytes and/or mesenchymal stem cells, and/or adult somatic cells. The process involves subjecting non-expanded tissue derivatives containing stem and multipotent elements, or non-embryonic stem cells and/or somatic cells obtained from tissue samples, to mixing with hyaluronic acid esterified with butyric and retinoic acids (HBR). Previous research has demonstrated that HBR can maximize cardiogenesis in mouse embryonic stem cells, enhance myocardial and vascular differentiation in human mesenchymal stem cells (hMSCs) from various sources, and yield preconditioning of hMSCs to enhance cardiovascular repair in animal models. HBR increases histone acetylation through histone deacetylase inhibitory action of the butyric moiety, affecting transcriptional expression of genes involved in cardiogenesis, vasculogenesis, cell survival, and synthesis of trophic mediators like VEGF and HGF. The method provides an alternative to viral vector-mediated gene delivery for cell reprogramming, offering a less cumbersome, expensive, and potentially safer approach for inducing pluripotency in somatic cells without requiring stem cell transplantation.

Related Research